Inovio Pharmaceuticals Inc (INO)

NASDAQ
7.790
-0.350(-4.30%)
Pre Market
7.800
+0.010(+0.13%)
- Real-time Data
  • Volume:
    3,654,270
  • Bid/Ask:
    7.680/8.000
  • Day's Range:
    7.680 - 8.130
  • Type:Equity
  • Market:United States
  • ISIN:US45773H2013
  • CUSIP:00045773H201

INO Overview

Prev. Close
8.14
Day's Range
7.68-8.13
Revenue
6.46M
Open
7.911
52 wk Range
5.84-18.98
EPS
-0.69
Volume
3,654,270
Market Cap
1.64B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
4,608,679
P/E Ratio
-
Beta
0.66
1-Year Change
-54.18%
Shares Outstanding
210,356,896
Next Earnings Date
10 Nov 2021
What is your sentiment on Inovio Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Inovio Pharmaceuticals Inc News

Inovio Pharmaceuticals Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellStrong SellSellSell
Technical IndicatorsStrong BuyStrong SellSellStrong SellStrong Sell
SummaryBuyStrong SellStrong SellStrong SellStrong Sell

Inovio Pharmaceuticals Inc Company Profile

Inovio Pharmaceuticals Inc Company Profile

Employees
262

Inovio Pharmaceuticals, Inc. (Inovio) is a late-stage biotechnology company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.

Read More
  • the price is gonna touch usd. 7.50 by end of this weeke and then shoot up to usd.14.00 by early next month. Gurustocks
    0
    • https://www.appliedclinicaltrialsonline.com/view/running-a-covid-vaccine-trial
      1
      • Zero target?
        1
        • Yeah i think you should go all in and short it to zero - go for it
          1
      • what is going on
        0
        • a $2B+ company with that is consistently losing money for years?
          0
      • Still seems to be a two pace forward and one back stock much like Moderna.
        3
        • Anyone know the target price?
          2
          • $75 if they get funding?
            0
        • mark my words this one and Novavax will win the race
          3
          • Force buying till 24
            1
            • By above day pivot keep buying 24 is possible today
              1
              • What happening. May be good idea exit
                0
                • Nice bubble to enjoy !!
                  0
                  • I don’t understand why Inovio increases value according to very clear and undoubtable steps/milestones (DoD’s 70M $, being close to reporting to phase 1 results just after DoD’s move, trials in S. Korea, Gates’ and Zuckerberg’s sponsoring, etc...), and Vaxart shoots up 200% in two days (and almost 3000%YTD - always related to CoVid19...) on the basis of their own proclamations and suppositions (having a vaccine ready in tablet form-!).
                    1
                    • 持股或买入,加仓,止损点5巴仙。
                      0
                      • Mark my words, this is a bubble!
                        4
                        • Jonny Trso u believe their research to be false
                          0
                        • Good luck with shorting.
                          0
                        • Here we go they spike
                          0
                      • I thought it can reach 13 today
                        1
                        • Why it dropped so bad ?
                          0
                          • Planning to go long this one. Any suggestions ??
                            0
                            • Let’s keep it
                              0
                              • Why the premarket movement is so pessimistic? 7.65 -1.85 (-19.47%)
                                0
                                • https://www.barchart.com/stocks/quotes/INO/opinion
                                  0
                                  • why has this dropped so much
                                    0
                                    • Citron ha postato un tweet screditando i risultati di Inovio che ha provocato un sell off ..
                                      0
                                      • Why is not 10?
                                        0
                                        • Shat is going on with this stock??
                                          0
                                          • Any news on vaccine?
                                            0
                                            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.